Skip to content
Optionomics Free · No account needed

Earnings analysis · 10-Q

MRAM earnings analysis

Filed April 29, 2026 · Our reading of the company's report

The latest report

Everspin Technologies (MRAM) reported Q1 2026 results with total revenue of $14.9 million, surpassing both the consensus estimate and the prior year's figure, which reflects a year-over-year increase of 13.2%. The…

Read full summary

Everspin Technologies (MRAM) reported Q1 2026 results with total revenue of $14.9 million, surpassing both the consensus estimate and the prior year's figure, which reflects a year-over-year increase of 13.2%. The company posted an EPS of $0.11, beating expectations and indicating improved financial performance despite a rise in operating expenses.

Read the original on SEC.gov

From revenue to operating profit

Where each $100 of revenue went in this report.

Of every $100 of revenue Cost of sales $47 Operating expenses $71 Left as operating profit $-18

Cost of sales, operating expenses, and what remained. Figures are rounded to whole dollars.

Reported figures

Earnings per share
$0.11

What stood out

  • Revenue Growth of 13.2%

    Total revenue increased from $13.1 million in Q1 2025 to $14.9 million in Q1 2026.

  • EPS Surpassed Expectations

    Reported EPS of $0.11 exceeded the estimated EPS of $0.09.

  • Strong Product Sales Increase

    Product sales grew 27.9% from $11 million in Q1 2025 to $14.1 million in Q1 2026.

  • Improved Gross Margin

    Gross margin improved from 51.4% in Q1 2025 to 52.7% in Q1 2026.

  • Significant Other Income Increase

    Other income increased by 442.8%, from $388,000 in Q1 2025 to $2.1 million in Q1 2026.

  • $40.5 Million Cash Position

    Cash and cash equivalents totaled $40.5 million as of March 31, 2026, down from $44.5 million at the end of 2025.

What to watch

  • Increased Operating Expenses

    Total operating expenses rose by 21.5%, from $8.7 million in Q1 2025 to $10.6 million in Q1 2026.

  • Potential Patent Infringement Risk

    Litigation costs associated with the patent infringement lawsuit could impact financial performance.

  • Decreased Licensing Revenue

    Licensing revenue dropped by 63.4%, from $2.1 million in Q1 2025 to $772,000 in Q1 2026.

Management's outlook

Q2 2026 revenue guidance is expected between $15.5 million and $16.5 million, with GAAP net loss per share guidance at $(0.12) to $(0.07).

This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.